Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!)
CLICK HERE
Stacey  Friedman net worth and biography

Stacey Friedman Biography and Net Worth

General Counsel of JPMorgan Chase & Co.
Stacey R. Friedman is a General Counsel of the Company. Prior to which she was Deputy General Counsel since July 2015 and General Counsel for the Corporate & Investment Bank since August 2012.

What is Stacey Friedman's net worth?

The estimated net worth of Stacey Friedman is at least $10.94 million as of February 22nd, 2024. Ms. Friedman owns 59,456 shares of JPMorgan Chase & Co. stock worth more than $10,939,309 as of February 24th. This net worth estimate does not reflect any other assets that Ms. Friedman may own. Learn More about Stacey Friedman's net worth.

How do I contact Stacey Friedman?

The corporate mailing address for Ms. Friedman and other JPMorgan Chase & Co. executives is 383 MADISON AVENUE, NEW YORK NY, 10179. JPMorgan Chase & Co. can also be reached via phone at (212) 270-6000 and via email at [email protected]. Learn More on Stacey Friedman's contact information.

Has Stacey Friedman been buying or selling shares of JPMorgan Chase & Co.?

Over the course of the past ninety days, Stacey Friedman has sold $1,101,861.90 of JPMorgan Chase & Co. stock. Most recently, Stacey Friedman sold 6,030 shares of the business's stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $182.73, for a transaction totalling $1,101,861.90. Following the completion of the sale, the general counsel now directly owns 59,456 shares of the company's stock, valued at $10,864,394.88. Learn More on Stacey Friedman's trading history.

Who are JPMorgan Chase & Co.'s active insiders?

JPMorgan Chase & Co.'s insider roster includes Ashley Bacon (Insider), Stephen Burke (Director), Reginald Chambers (CFO & Head of Strategy for Commercial Banking), James Dimon (Chairman & CEO ), Mary Erdoes (CEO), Stacey Friedman (General Counsel), Nicole Giles (Insider), Mellody Hobson (Director), Marianne Lake (EVP), Douglas Petno (CEO), Jennifer Piepszak (CFO), Daniel Pinto (CEO), Peter Scher (EVP), and Gordon Smith (CEO). Learn More on JPMorgan Chase & Co.'s active insiders.

Are insiders buying or selling shares of JPMorgan Chase & Co.?

During the last year, insiders at the financial services provider sold shares 19 times. They sold a total of 1,032,107 shares worth more than $180,660,497.15. The most recent insider tranaction occured on February, 22nd when CEO James Dimon sold 821,778 shares worth more than $150,163,493.94. Insiders at JPMorgan Chase & Co. own 0.8% of the company. Learn More about insider trades at JPMorgan Chase & Co..

Information on this page was last updated on 2/22/2024.

Stacey Friedman Insider Trading History at JPMorgan Chase & Co.

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2024Sell6,030$182.73$1,101,861.9059,456View SEC Filing Icon  
9/6/2023Sell4,310$144.86$624,346.6053,425View SEC Filing Icon  
8/7/2023Sell4,310$157.16$677,359.6057,735View SEC Filing Icon  
1/17/2023Sell23,148$140.31$3,247,895.8848,311View SEC Filing Icon  
4/15/2021Sell16,965$150.90$2,560,018.50
1/15/2020Sell6,441$137.10$883,061.1036,559View SEC Filing Icon  
4/15/2019Sell3,710$109.75$407,172.5023,650View SEC Filing Icon  
1/29/2019Sell3,022$105.00$317,310.0012,519View SEC Filing Icon  
1/17/2018Sell17,729$112.33$1,991,498.5721,260View SEC Filing Icon  
10/26/2017Sell2,099$101.96$214,014.0415,279View SEC Filing Icon  
8/21/2017Sell9,968$90.55$902,602.4010,527View SEC Filing Icon  
4/17/2017Sell10,792$85.07$918,075.4463,344View SEC Filing Icon  
10/26/2016Sell2,099$69.03$144,893.974,752View SEC Filing Icon  
1/15/2016Sell7,296$56.81$414,485.76View SEC Filing Icon  
See Full Table

Stacey Friedman Buying and Selling Activity at JPMorgan Chase & Co.

This chart shows Stacey Friedman's buying and selling at JPMorgan Chase & Co. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

JPMorgan Chase & Co. Company Overview

JPMorgan Chase & Co. logo
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services to consumers and small businesses; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt markets capital-raising services, as well as loan origination and syndication; payments and cross-border financing; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations; and commercial real estate banking services to investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products. The company also provides ATM, online and mobile, and telephone banking services. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Read More

Today's Range

Now: $183.99
Low: $183.19
High: $185.20

50 Day Range

MA: $172.55
Low: $166.25
High: $183.99

2 Week Range

Now: $183.99
Low: $123.11
High: $185.20

Volume

7,105,833 shs

Average Volume

7,787,549 shs

Market Capitalization

$529.96 billion

P/E Ratio

11.34

Dividend Yield

2.32%

Beta

1.14
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Get all the details here >>>